La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « trials »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
trial < trials < triangles  Facettes :

List of bibliographic references indexed by trials

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000107 (2017) Alberto J. Espay [États-Unis] ; Anthony E. Lang [Canada]Common Myths in the Use of Levodopa in Parkinson Disease: When Clinical Trials Misinform Clinical Practice.
000118 (2017) Alberto J. Espay [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Caroline M. Tanner [États-Unis] ; Hubert H. Fernandez [États-Unis] ; David K. Simon [États-Unis] ; James B. Leverenz [États-Unis] ; Aristide Merola [États-Unis] ; Alice Chen-Plotkin [États-Unis] ; Patrik Brundin [États-Unis] ; Marcelo A. Kauffman [Argentine] ; Roberto Erro [Royaume-Uni] ; Karl Kieburtz [États-Unis] ; Daniel Woo [États-Unis] ; Eric A. Macklin [États-Unis] ; David G. Standaert [États-Unis] ; Anthony E. Lang [Canada]Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.
000406 (2016) Erika F. Augustine [États-Unis] ; E Ray Dorsey [États-Unis] ; Robert A. Hauser [États-Unis] ; Jordan J. Elm [États-Unis] ; Barbara C. Tilley [États-Unis] ; Karl K. Kieburtz [États-Unis]Communicating with participants during the conduct of multi-center clinical trials.
000439 (2016) Anne-Marie A. Wills [États-Unis] ; Adriana Pérez ; Jue Wang ; Xiao Su ; John Morgan ; Suja S. Rajan ; Maureen A. Leehey ; Gregory M. Pontone [États-Unis] ; Kelvin L. Chou ; Chizoba Umeh [États-Unis] ; Zoltan Mari [États-Unis] ; James BoydAssociation Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
000493 (2015) Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada]The promise of futility trials in neurological diseases.
000559 (2015) Marina Picillo [Italie] ; Nancy Kou [Canada] ; Paolo Barone [Italie] ; Alfonso Fasano [Canada]Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards.
000674 (2015) Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan DubowIntegrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
000754 (2015) Avril Mansfield [Canada] ; Jennifer S. Wong [Canada] ; Jessica Bryce ; Svetlana Knorr ; Kara K. Patterson [Canada]Does perturbation-based balance training prevent falls? Systematic review and meta-analysis of preliminary randomized controlled trials.
000864 (2014) Olivier Godefroy [France] ; Laura Gibbons [États-Unis] ; Momar Diouf [France] ; David Nyenhuis [États-Unis] ; Martine Roussel [France] ; Sandra Black [Canada] ; Jean Marc Bugnicourt [France]Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials
000894 (2014) Spencer Phillips Hey ; Jonathan KimmelmanThe questionable use of unequal allocation in confirmatory trials
000E10 (2013) Wendy R. Galpern [États-Unis] ; Christopher S. Coffey [États-Unis] ; Alberto Albanese [Italie] ; Ken Cheung [États-Unis] ; Cynthia L. Comella [États-Unis] ; Dixie J. Ecklund [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Karl Kieburtz [États-Unis] ; Anthony E. Lang [Canada] ; Michael P. Mcdermott [États-Unis] ; Jeremy M. Shefner [États-Unis] ; Jan K. Teller [États-Unis] ; John L. P. Thompson [États-Unis] ; Sharon D. Yeatts [États-Unis] ; H. A. Jinnah [États-Unis]Designing Clinical Trials for Dystonia
000E67 (2013) Lehana Thabane [Canada] ; Lawrence Mbuagbaw [Canada] ; Shiyuan Zhang [Canada] ; Zainab Samaan [Canada] ; Maura Marcucci [Canada] ; Chenglin Ye [Canada] ; Marroon Thabane [Canada] ; Lora Giangregorio [Canada] ; Brittany Dennis [Canada] ; Daisy Kosa [Canada] ; Victoria Borg Debono [Canada] ; Rejane Dillenburg [Canada] ; Vincent Fruci [Canada] ; Monica Bawor [Canada] ; Juneyoung Lee [Corée du Sud] ; George Wells [Canada] ; Charles H. Goldsmith [Canada]A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
000E88 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
001021 (2013) Pankaj A. Agarwal [Canada] ; A. Jon Stoessl [Canada]Biomarkers for trials of neuroprotection in Parkinson's disease
001238 (2012) Jonathan Kimmelman [Canada]Ethics, ambiguity aversion, and the review of complex translational clinical trials.
001447 (2012) Jordan J. Elm [États-Unis]Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long‐Term Study–1
001611 (2011) Jonathan Kimmelman [Canada] ; Alex John London [États-Unis]Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty
001802 (2011) Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials
001813 (2011) Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
001893 (2011) Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
001898 (2011) Anthony E. Lang [Canada]A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "trials" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "trials" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    trials
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022